Long‐term remission in gout: Challenges and future opportunities

Abstract Among rheumatic diseases, the prevalence of gout is increasing with population growth and aging. While hyperuricemia remains the major risk factor, gout is now recognized as a curable disease. Several recommendations have been proposed to achieve treatment goals; however, only a small proportion of patients receive adequate management and achieve target serum urate levels. Without proper management, patients often experience gout flares, which can be triggered by multiple risk factors. Recently, tools and criteria have been developed to assess disease activity and define clinical remission in gout. Therefore, this review aims to highlight factors that precipitate gout flares, summarize evidence supporting complete disease control, outline principles and strategies for long‐term management, and provide potential future perspectives.